MAPT and amyloidosis: Second, we defined amyloid PET thresholds signaling the transition from amyloidosis to tauopathy, determined as the minimum Centiloid level at which annual temporal meta‐tau PET change rates exceeded the z score thresholds for mild/moderate/severe tauopathy (Figure 2A).